Meet us at Pitti Filati (25. – 27. June 2024) and Première Vision (2. – 4. July 2024)!

Meet us at Pitti Filati (25. – 27. June 2024) and Première Vision (2. – 4. July 2024)!

Our shareholders

Our shareholders fully support our vision to make the world’s best and most sustainable biomaterials accessible to everyone. Together, we have the goal of making AMSilk a global leader in bioengineered performance materials. In 2008, AMSilk was founded as spin-off from the Technical University of Munich. Thanks to the support of the shareholders AT Newtec GmbH and MIG Fonds, we were able to grow from a humble startup into a well-established, reputable industry partner in the field of biomaterial products. We are grateful that our initial shareholders have supported us since the very beginning of our journey. In 2021, additional and renowned shareholders joined the Company, supporting us to make the next step.

Together with our existing shareholders and with Novo Holdings, Cargill and E.R. Capital Holding, we can accelerate industrialization and expand commercial operations into new markets.

Our shareholders fully support our vision to make the world’s best and most sustainable biomaterials accessible to everyone - AMSilk

Our strong investor network to support our mission

AMSilk - Supported by our shareholders - Athos

AT Newtec GmbH
The Hexal founders Dr. Andreas and Dr. Thomas Strüngmann are majority shareholders of AMSilk GmbH through AT Newtec GmbH. The brothers invest in companies at different growth stages and are also the major shareholders of Biontech.

AMSilk - Supported by our shareholders - MIG Verwaltungs AG

MIG
MIG AG, Munich, is one of the leading German VC investors. MIG invests through MIG Fonds in young, deep tech and life science companies in German-speaking Europe and beyond. To date, the company has invested more than € 600 million in over 40 companies.

AMSilk - Supported by our shareholders - Novo Holdings

Novo Holdings
Novo Holdings is recognized as a leading life science investor with a focus on creating long-term value. As a life sciences investor, Novo Holdings provides seed and venture capital to development-stage companies and takes significant ownership positions in growth and well-established companies. Novo Holdings also manages a broad portfolio of diversified financial assets.

AMSilk - Supported by our shareholders - Cargill

Cargill
Cargill’s 155,000 employees across 70 countries work relentlessly to achieve our purpose of nourishing the world in a safe, responsible and sustainable way. We combine 155 years of experience with new technologies and insights to serve as a trusted partner for food, agriculture, financial and industrial customers in more than 125 countries. Side-by-side, we are building a stronger, sustainable future for agriculture.

AMSilk - Supported by our shareholders - E.R. Capital Holding

E.R. Capital Holding
The E.R. Capital Holding is a private investment and asset management group with a global outreach based in the City of Hamburg. Its investments are focused on real estate, renewable energies, and shipping as well as innovations in cleantech and biotech.

AMSilk - Supported by our shareholders - TUM

TUM
Technische Universität München (TUM) is one of Europe’s top universities. The university forges strong links with companies and scientific institutions across the world. TUM was one of the first universities in Germany to be named a University of Excellence. Moreover, TUM regularly ranks among the best European universities in international rankings.

First-hand information for our shareholders and for investors

AMSilk Announces Extension of Series C Financing to EUR 54M

AMSilk GmbH (“AMSilk”), the world’s first industrial supplier of bio-fabricated silk protein materials, today announced it has successfully raised an additional EUR 25 million in an extended Series C financing led by existing investor ATHOS (AT Newtec) with participation from Novo Holdings, Cargill, and MIG Capital.

AMSilk raises EUR 29 M to accelerate commercialization of its high-performance bio-based silk polymers

Financing led by Novo Holdings with participation from Cargill and ER Capital Holdings. AMSilk to accelerate industrial scale-up and expand commercial operations into new markets.

IR Contact | Investor Relations

Are you curious about investing in AMSilk or have any queries regarding our company? We’re here to assist and provide valuable insights into investment prospects. Feel free to contact us for further assistance. Let’s explore the world of investments together!

Innovation needs collaboration - Partnership with AMSilk